In cardiac diseases, TGFBR1 is mainly involved in myocardial fibrosis, and inhibition of its expression can reduce collagen deposition and improve cardiac function through the Smad signaling pathway [60,61]. Here, TGFBR1 is linked to Myocardial fibrosis.